Cumberland Pharmaceuticals, Inc. (CPIX)
6.62
-0.17
(-2.50%)
USD |
NASDAQ |
Sep 08, 16:00
6.80
+0.18
(+2.72%)
Pre-Market: 08:37
Cumberland Pharmaceuticals Total Assets (Quarterly) : 62.88M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 62.88M |
| March 31, 2026 | 71.00M |
| December 31, 2025 | 76.82M |
| September 30, 2025 | 65.90M |
| June 30, 2025 | 67.91M |
| March 31, 2025 | 69.94M |
| December 31, 2024 | 75.58M |
| September 30, 2024 | 76.75M |
| June 30, 2024 | 78.52M |
| March 31, 2024 | 81.51M |
| December 31, 2023 | 81.78M |
| September 30, 2023 | 87.75M |
| June 30, 2023 | 89.38M |
| March 31, 2023 | 89.47M |
| December 31, 2022 | 92.93M |
| September 30, 2022 | 90.78M |
| June 30, 2022 | 92.52M |
| March 31, 2022 | 96.70M |
| December 31, 2021 | 84.46M |
| September 30, 2021 | 87.57M |
| June 30, 2021 | 88.85M |
| March 31, 2021 | 93.35M |
| December 31, 2020 | 97.13M |
| September 30, 2020 | 96.01M |
| June 30, 2020 | 97.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 97.42M |
| December 31, 2019 | 105.86M |
| September 30, 2019 | 103.77M |
| June 30, 2019 | 107.55M |
| March 31, 2019 | 114.62M |
| December 31, 2018 | 114.67M |
| September 30, 2018 | 87.43M |
| June 30, 2018 | 90.44M |
| March 31, 2018 | 91.09M |
| December 31, 2017 | 95.30M |
| September 30, 2017 | 90.35M |
| June 30, 2017 | 87.80M |
| March 31, 2017 | 91.86M |
| December 31, 2016 | 96.64M |
| September 30, 2016 | 91.07M |
| June 30, 2016 | 87.89M |
| March 31, 2016 | 89.21M |
| December 31, 2015 | 91.92M |
| September 30, 2015 | 92.06M |
| June 30, 2015 | 92.92M |
| March 31, 2015 | 92.19M |
| December 31, 2014 | 95.41M |
| September 30, 2014 | 93.90M |
| June 30, 2014 | 93.47M |
| March 31, 2014 | 91.11M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 45.77M |
| Shareholders Equity (Quarterly) | 17.44M |
| Debt to Equity Ratio | 0.2703 |
| Current Ratio | 0.9559 |
| Net Debt Paydown Yield | 1.18% |